Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference24 articles.
1. Should antipsychotic medications for schizophrenia be given for a lifetime? A naturalistic long-term follow-up study;J Clin Psychopharmacol,2017
2. Antipsychotic drug versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis;Lancet,2012
3. Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients;BMC Psychiatry,2009
4. Comparative effectiveness ofAntipsychotic drugs for rehospitalization in schizophrenia-a nationwide study with 20-year follow-up;Schizophr Bull,2018
5. A qualitative study of experiences with and perceptions regarding long-actinginjectable antipsychotics: part II-physician perspectives;Can J Psychiatry,2013
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data;Mental Health Clinician;2023-08-01
2. Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery;BMC Psychiatry;2023-06-21
3. Psychiatric Nurses’ Knowledge and Practice Barriers to Administering Long-Acting Injectable (LAI) Antipsychotics in Taiwan: A Mixed-Methods Study;Healthcare;2023-06-06
4. Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery;2023-03-08
5. Pharmacist Administration of Long-Acting Injectable Antipsychotics to Community-Dwelling Patients: A Scoping Review;Pharmacy;2023-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3